Laserfiche WebLink
opioids are a primary substance of abuse,both the DSM 5 Criteria for the Diagnosis of Opioid <br />Use Disorder and the Clinical Opioid Withdrawal Scale will be utilized.Assessment for other <br />SUDs and withdrawals will also occur during initial screening.For example,if alcohol is <br />identified as a substance of abuse,the DSM S Criteria for the Diagnosis of Alcohol Use Disorder <br />and the Clinical Institute Withdrawal Assessment for Alcohol will be used.A combination of <br />screening/assessment instruments as well as the individual characteristics of each patient will be <br />used to identify appropriate and willing candidates for MAT.The screening flow is demonstrated <br />in Figure 3 below. <br />Figure 3.Inmate flow <br />GAIN-SS <br />jfo¯king/Triage <br />-,,•Urinedrugscreen <br />Screening for SUD history <br />I Substance Use <br />Disorder (SUD} <br />Screened in for en SUD not <br />i Alcohol Use Benzodiazepine Oploid Agonist arnandable to i <br />No SUDDisorderUseDisorderTherapyMedication- <br />(OAT)Assessment Assisted Treatment <br />Clinical institute Clinical Opiate !Cleared for Cleared for iWithdrawalMedicallyWlanagedWithdrawalScaleclassificationfor--chassificationfor <br />(C <br />eA}Sment Withdrawal (COWS)Score |housing housing <br />Me drMaareged Medical cla a i for <br />housing <br />Medical <br />While local MAT program medication options may include buprenorphine HCL,Naltrexone <br />HCL,and Vivitrol IM,the Jail MAT program will only offer Buprenorphine HCL at this time. <br />Onsite Services <br />Intake:A full-time onsite Nurse Care Manager (NCM)will assist each imnate who has been <br />pre-screened using an evidence-based screening tool provided by the MAT partner organization, <br />and identified as a candidate for MAT by the jail correctional or medical staff,to complete new <br />9 of 20